ACI
IBB icon

AMP Capital Investors’s iShares Biotechnology ETF IBB Stock Holding History

AMP Capital Investors’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-41,310
Closed -$5.56M – 1273
2020
Q2 		$5.56M Buy
+41,310
New +$5.27M 0.04% 466
2018
Q1 		– Sell
-240,100
Closed -$25.6M – 1190
2017
Q4 		$25.6M Buy
+240,100
New +$25.7M 0.14% 181
2017
Q3 		– Sell
-125,700
Closed -$13.1M – 1152
2017
Q2 		$13.1M Buy
+125,700
New +$12.4M 0.08% 277

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
CM
Churchill Management Los Angeles, California $9.21B AUM 19.91% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

AMP Capital Investors's IBB Position: Q3 2020 in Review

AMP Capital Investors sold out of iShares Biotechnology ETF (IBB) in Q3 2020, closing a stake of 41,310 shares — an estimated $5.56M sold.

AMP Capital Investors first reported a position in IBB in Q2 2017 and held it in 3 quarters. The position peaked at $25.6M in Q4 2017. 784 funds tracked by Wall St. Rank hold IBB as of Q3 2020.

  • AMP Capital Investors reported no remaining iShares Biotechnology ETF position as of Q3 2020 after selling out during the quarter.
  • AMP Capital Investors sold 41,310 iShares Biotechnology ETF shares in Q3 2020, an estimated $5.56M.
  • AMP Capital Investors first reported a position in iShares Biotechnology ETF in Q2 2017 and held it in 3 quarters.
  • AMP Capital Investors's iShares Biotechnology ETF position peaked at $25.6M in Q4 2017.
  • 784 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2020.

Based on AMP Capital Investors's 13F filing for Q3 2020, filed 12 Nov 2020.